Evaluating ANI Pharmaceuticals: Insights From 5 Financial Analysts
ANI Pharmaceuticals (NASDAQ:ANIP) has been analyzed by 5 analysts in the last three months, revealing a diverse range…
Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here’s What You Need To Know
Truist Securities has decided to maintain its Buy rating of ANI Pharmaceuticals (NASDAQ:ANIP) and raise its price target…
Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today?
ANI Pharmaceuticals Inc's (NASDAQ: ANIP) third-quarter revenues were $131.8 million, up 57.3% Y/Y, beating the
Earnings Scheduled For November 8, 2023
Companies Reporting Before The Bell
• Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Expert Ratings for ANI Pharmaceuticals
Over the past 3 months, 6 analysts have published their opinion on ANI Pharmaceuticals (NASDAQ:ANIP) stock. These analysts…
Analyst Expectations for ANI Pharmaceuticals’s Future
Analysts have provided the following ratings for ANI Pharmaceuticals (NASDAQ:ANIP) within the last quarter: Bullish Somewhat Bullish Indifferent…
What 4 Analyst Ratings Have To Say About ANI Pharmaceuticals
Analysts have provided the following ratings for ANI Pharmaceuticals (NASDAQ:ANIP) within the last quarter: Bullish Somewhat Bullish Indifferent…
Earnings Scheduled For August 9, 2023
Companies Reporting Before The Bell
• Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.
Where ANI Pharmaceuticals Stands With Analysts
Within the last quarter, ANI Pharmaceuticals (NASDAQ:ANIP) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Looking Into ANI Pharmaceuticals’s Return On Capital Employed
According to Benzinga Pro, during Q1, ANI Pharmaceuticals (NASDAQ:ANIP) earned $1.44 million, a 133.91% increase from the preceding…